U.S. Markets closed

Vital Therapies (VTL) Catches Eye: Stock Surges 20.7%

Zacks Equity Research

Vital Therapies, Inc. (VTL) was a big mover last session with its shares surging nearly 21% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the phenomenal uptrend of the company as the stock has gained over 129% in the past one-month time frame.

This biotherapeutic company has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Vital Therapies currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Investors interested in the biomedical industry may consider better-ranked stocks like ANIP Pharmaceuticals, Inc. (ANIP), Gilead Sciences Inc. (GILD) and Illumina Inc. (ILMN). All the three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

VITAL THERAPIES INC (VTL): Free Stock Analysis Report

ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report

GILEAD SCIENCES INC (GILD): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report

Zacks Investment Research